These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 28494252)
1. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors. Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943 [TBL] [Abstract][Full Text] [Related]
4. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and antihepatitis B virus activities of novel 2-pyridone derivatives. Lv Z; Sheng C; Wang T; Zhang Y; Liu J; Feng J; Sun H; Zhong H; Niu C; Li K J Med Chem; 2010 Jan; 53(2):660-8. PubMed ID: 20000776 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents. Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of new N(4)-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents. Lv Z; He W; Tian X; Kang J; Liu Y; Peng Y; Zheng L; Wang Q; Yu W; Chang J Eur J Med Chem; 2015 Aug; 101():103-10. PubMed ID: 26119991 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors. Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009 [TBL] [Abstract][Full Text] [Related]
9. A new series of HAPs as anti-HBV agents targeting at capsid assembly. Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors. Li Z; Min Q; Huang H; Liu R; Zhu Y; Zhu Q Bioorg Med Chem Lett; 2018 May; 28(9):1501-1506. PubMed ID: 29627260 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of caudatin analogs as potent hepatitis B virus inhibitors. Wang LJ; Chen H; Ma YB; Huang XY; Geng CA; Zhang XM; Chen JJ Med Chem; 2015; 11(2):165-79. PubMed ID: 25181984 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and bioevaluation of paeonol derivatives as potential anti-HBV agents. Huang TJ; Chuang H; Liang YC; Lin HH; Horng JC; Kuo YC; Chen CW; Tsai FY; Yen SC; Chou SC; Hsu MH Eur J Med Chem; 2015 Jan; 90():428-35. PubMed ID: 25461891 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. Liu S; Li Y; Wei W; Wang K; Wang L; Wang J Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103 [TBL] [Abstract][Full Text] [Related]
15. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors. Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X Bioorg Med Chem; 2018 May; 26(8):1573-1578. PubMed ID: 29459146 [TBL] [Abstract][Full Text] [Related]
16. Tryptamine derivatives as novel non-nucleosidic inhibitors against hepatitis B virus. Qu SJ; Wang GF; Duan WH; Yao SY; Zuo JP; Tan CH; Zhu DY Bioorg Med Chem; 2011 May; 19(10):3120-7. PubMed ID: 21524588 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region. Yu J; Jia H; Guo X; Desta S; Zhang S; Zhang J; Ding X; Liang X; Liu X; Zhan P Chem Biol Drug Des; 2020 Jun; 95(6):567-583. PubMed ID: 30825248 [TBL] [Abstract][Full Text] [Related]
18. Optimization and Synthesis of Pyridazinone Derivatives as Novel Inhibitors of Hepatitis B Virus by Inducing Genome-free Capsid Formation. Lu D; Liu F; Xing W; Tong X; Wang L; Wang Y; Zeng L; Feng C; Yang L; Zuo J; Hu Y ACS Infect Dis; 2017 Mar; 3(3):199-205. PubMed ID: 27989113 [TBL] [Abstract][Full Text] [Related]
19. Anti-hepatitis B virus and anti-cancer activities of novel isoflavone analogs. Zhang Y; Zhong H; Lv Z; Zhang M; Zhang T; Li Q; Li K Eur J Med Chem; 2013 Apr; 62():158-67. PubMed ID: 23353737 [TBL] [Abstract][Full Text] [Related]
20. Assessment of quinazolinone derivatives as novel non-nucleoside hepatitis B virus inhibitors. Qiu J; Chen W; Zhang Y; Zhou Q; Chen J; Yang L; Gao J; Gu X; Tang D Eur J Med Chem; 2019 Aug; 176():41-49. PubMed ID: 31091479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]